comparemela.com

Latest Breaking News On - Zimmer biomet company profile - Page 1 : comparemela.com

Bellevue Group AG Sells 3,800 Shares of Zimmer Biomet Holdings, Inc (NYSE:ZBH)

Bellevue Group AG cut its holdings in Zimmer Biomet Holdings, Inc. (NYSE:ZBH – Free Report) by 1.3% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 281,088 shares of the medical equipment provider’s stock after selling 3,800 shares during the period. Bellevue […]

Bellevue Group AG Sells 3,800 Shares of Zimmer Biomet Holdings, Inc (NYSE:ZBH)

Bellevue Group AG cut its holdings in Zimmer Biomet Holdings, Inc. (NYSE:ZBH – Free Report) by 1.3% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 281,088 shares of the medical equipment provider’s stock after selling 3,800 shares during the period. Bellevue […]

Zimmer Biomet Holdings, Inc (NYSE:ZBH) Position Lifted by Sompo Asset Management Co Ltd

Sompo Asset Management Co. Ltd. grew its position in Zimmer Biomet Holdings, Inc. (NYSE:ZBH – Free Report) by 15.5% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 3,960 shares of the medical equipment provider’s stock after acquiring an additional 530 shares during the […]

Vinva Investment Management Ltd Purchases 6,059 Shares of Zimmer Biomet Holdings, Inc (NYSE:ZBH)

Vinva Investment Management Ltd grew its position in shares of Zimmer Biomet Holdings, Inc. (NYSE:ZBH – Free Report) by 88.9% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 12,876 shares of the medical equipment provider’s stock after purchasing an additional 6,059 shares during […]

Zimmer Biomet Holdings, Inc (NYSE:ZBH) Receives $134 40 Consensus PT from Analysts

Zimmer Biomet Holdings, Inc. (NYSE:ZBH – Get Free Report) has earned an average rating of “Hold” from the sixteen analysts that are currently covering the firm, MarketBeat reports. One research analyst has rated the stock with a sell recommendation, nine have assigned a hold recommendation and six have assigned a buy recommendation to the company. […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.